Skip to main content
Full access
Articles
Published Online: 12 October 2022

Established Outpatient Care and Follow-Up After Acute Psychiatric Service Use Among Youths and Young Adults

Abstract

Objective:

This study explored follow-up after hospitalization and emergency room (ER) use for mental health among youths and young adults with private insurance.

Methods:

The IBM MarketScan commercial database (2013–2018) was used to identify people ages 12–27 with a mental health hospitalization (N=95,153) or ER use (N=108,576). Factors associated with outpatient mental health follow-up within 7 and 30 days of discharge were determined via logistic models with generalized estimating equations that accounted for state variation.

Results:

Of those hospitalized, 42.7% received follow-up within 7 days (67.4% within 30 days). Of those with ER use, 28.6% received follow-up within 7 days (46.4% within 30 days). Type of established outpatient care predicted follow-up after hospitalization and ER use. Compared with people with no established care, the likelihood of receiving follow-up within 7 days was highest among those with mental health and primary care (hospitalization, adjusted odds ratio [AOR]=2.81, 95% confidence interval [CI]=2.68–2.94; ER use, AOR=4.06, 95% CI=3.72–4.42), followed by those with mental health care only (hospitalization, AOR=2.57, 95% CI=2.45–2.70; ER use, AOR=3.48, 95% CI=3.17–3.82) and those with primary care only (hospitalization, AOR=1.20, 95% CI=1.15–1.26; ER use, AOR=1.22, 95% CI=1.16–1.28). Similar trends were observed within 30 days of discharge.

Conclusions:

Follow-up rates after acute mental health service use among youths and young adults were suboptimal. Having established mental health care more strongly predicted receiving follow-up than did having established primary care. Improving engagement with outpatient mental health care providers may increase follow-up rates.

HIGHLIGHTS

Of youths and young adults who visited the emergency room for a mental health reason, 28.6% received follow-up within 7 days and 46.4% within 30 days.
Follow-up within 7 days of discharge from a hospitalization for mental health was observed among 42.7% of youths and young adults (67.4% within 30 days).
The strongest predictor of receiving follow-up was having established primary and mental health care during the 6 months prior to acute service use.
Follow-up rates were notably low among those with a comorbid substance use disorder.
In 2021, the Surgeon General of the United States (1) and the Centers for Disease Control and Prevention (2) warned of an accelerating mental health crisis among adolescents. During 2021, 44.2% of high school students experienced persistent sadness or hopelessness, 19.9% seriously considered suicide, and 9.0% attempted suicide (3). Rates of hospitalization and emergency room (ER) use for a mental condition and substance use disorder are increasing (4, 5). In 2012, mental and substance use disorders were among the top 10 reasons for teen hospitalization (6), and from 2009 to 2015, ER visits for mental health reasons increased by 56.4% among pediatric patients and by 40.8% among adults (7).
Efforts to improve the quality of care for youths and young adults with mental health conditions include increasing rates of follow-up care after acute mental health service use (i.e., hospitalizations and ER use). Follow-ups with a mental health care provider within 7 and 30 days are national quality measures (8, 9) associated with improved medication adherence, decreased suicide risk, and increased long-term health care engagement (10, 11). Although about half of Medicaid-insured youths and young adults receive outpatient mental health care follow-up (10, 12), follow-up rates among youths and young adults with private insurance are unknown. Youths and young adults may experience unique challenges because they typically interact with multiple systems and agencies (13, 14) and may be underserved in current mental health systems (15). This study sought to determine rates and predictors of mental health care follow-up within 7 and 30 days of a hospitalization or ER use for a mental health condition among youths and young adults with private insurance and to examine differences by age group.

Methods

Stakeholder Engagement

Stakeholders included representatives from key organizations (see Table S1 in the online supplement to this article). Two 1.5-hour virtual forums elicited stakeholder perspectives (one before study launch to ensure the research generated relevant knowledge and one to share preliminary findings to gain real-world insight into data interpretation).

Data Set

This study used the IBM MarketScan commercial database (2013–2018), one of the largest collections of nationally representative patient data in the United States (16). These data include comprehensive, deidentified health insurance claims across the continuum of care (e.g., inpatient, outpatient, carve-out behavioral health care) from large employers and health plans that provide private health care coverage for employees, spouses, and dependents (16).
The database’s inpatient admissions table summarizes information about a hospital admission by using certain criteria (e.g., claims related to room and board). The admissions table includes all encounters associated with an admission, as well as a variable indicating the principal diagnosis (i.e., the main reason for admission). The database’s outpatient services table includes claims for services in doctors’ offices, hospital outpatient facilities, and ERs. ER use claims are defined by place of service, revenue, procedure, or service subcategory code (see Table S2 in the online supplement) (17). The outpatient table includes the first-listed diagnosis associated with the ER use claims.

Study Sample

We created two samples defined by health care setting: inpatients (hospitalization) and those using the ER. Both samples included patients ages 12–27 who had an acute event stemming from a mental health condition (i.e., major depressive disorder, bipolar disorder, schizophrenia, other psychotic disorders, anxiety disorders or phobias, posttraumatic stress disorder [PTSD], and disruptive disorders) (see Table S3 in the online supplement). Individuals with a self-harm or suicide-related code were also included, as were patients with a primary diagnosis of eating disorders or substance use disorder who had a psychiatric diagnosis or a self-harm or suicide-related claim coded with the remaining diagnosis codes. Those still receiving care at discharge from an inpatient hospitalization (i.e., transferred to another facility, still a patient, other) or who had missing data were excluded, as were those whose mental health or substance use claims were not covered or were suppressed. If an ER visit resulted in an inpatient admission, the patient was included in the inpatient sample rather than in the ER sample. Patients without continuous insurance coverage during the study period, those missing information on health plan coverage, or those who had a subsequent inpatient or ER visit before an outpatient follow-up visit were excluded. The final samples included 95,153 inpatients and 108,576 ER patients (Figures S1 and S2 in the online supplement). This retrospective cohort study was deemed to be non–human subjects research by the institutional review board of the University of Massachusetts Chan Medical School.

Outcome Measures

We created two primary binary outcome variables: outpatient mental health follow-up within 7 and within 30 days of discharge from the acute mental health visit. These variables were created to align with national quality measures defined in the Healthcare Effectiveness Data and Information Set (HEDIS) (8, 9). HEDIS specifications for follow-up exclude acute visits that are followed by readmission to inpatient care settings within 30 days of the initial acute care visit; thus, we included these visits only when outpatient follow-up care occurred prior to the readmission. Outpatient mental health care was defined as a visit with a specialty mental health care provider (e.g., psychiatrist, child psychiatrist) for evaluation, management, psychotherapy, or other psychiatric care, including psychiatric facility partial hospitalizations (Table S4 in the online supplement).
Secondary outcomes included any follow-up care (primary care, outpatient mental health care). Primary care use included visits with a primary care provider (e.g., internal medicine, family practice, or pediatric provider) for health promotion, disease prevention, health maintenance, or patient education in an outpatient setting (18). Outpatient care was categorized as primary care or as mental health care, according to provider type, Current Procedural Terminology codes, and place of service; outpatient mental health care was further defined through the specific place of service or service subcategory codes (Table S4 in the online supplement). Analyses for those with comorbid substance use examined follow-up care specifically for substance use (Table S5 in the online supplement).

Exposure Measure

The primary determinant was established outpatient care, defined as having had at least one visit with a provider in the 6 months prior to the acute mental health event. Use in the 6 months prior to acute care was explored because of previous research examining established care and follow-up rates (12). Established outpatient care was categorized as primary care and mental health care, mental health care only, primary care only, or none, according to the definitions for outpatient care described above.

Covariates

Covariates included age at time of service (categorized as 12–17 or 18–27), sex (male or female), health care plan type, psychiatric diagnosis, whether the acute event was self-harm or suicide related, and medical complexity. Health care plan type was categorized as high deductible or consumer driven; basic, major medical, or comprehensive; preferred provider organization; and all others (exclusive provider organization, health maintenance organization, point-of-service plans). Acute mental health service use was categorized as self-harm or suicide related if the event included any diagnosis code related to suicide (Table S3 in the online supplement). Inpatient data included length of hospital stay (≤3 days, 4–6 days, 7–10 days, or ≥11 days) and whether the individual left against medical advice. Medical complexity was measured by the Pediatric Medical Complexity Algorithm (less conservative version 3.1) (19). The psychiatric diagnoses used to define our sample were removed from the algorithm. Individuals’ conditions were classified as complex chronic (more than one body system involved or one or more progressive or malignant conditions), noncomplex chronic (one body system involved, not progressive or malignant), and nonchronic disease.

Data Analysis

We estimated the proportion of patients who received outpatient mental health care within 7 days and 30 days of discharge and describe characteristics overall and by the presence of outpatient mental health follow-up. We focused on absolute differences of ≥5% because seemingly trivial differences are likely to be statistically significant with large samples. We quantified the association of established outpatient care with the presence of outpatient mental health follow-up after an acute mental health event and adjusted the analyses for the available patient-level covariates by using generalized estimating equation models to account for clustering by state. Adjusted odds ratios (AORs) and corresponding 95% confidence intervals (CIs) were estimated. Analyses examined the distribution of established outpatient care by covariate (Tables S6 and S7 in the online supplement) and factors associated with any follow-up (Tables S8 and S9 in the online supplement), stratified by 2-year age intervals (Tables S10 and S11 in the online supplement) and psychiatric diagnosis (Tables S12 and S13 in the online supplement).

Results

Hospitalizations

Average inpatient age was 18.9 years. The most common length of stay in the hospital was 4–6 days, and 1.5% left against medical advice (Table 1). The most common primary diagnosis was major depression (53.7%), followed by bipolar disorder (22.3%); least common were PTSD (0.9%), comorbid eating disorders (1%), and disruptive disorders (1%). Self-harm, suicidal ideation, or suicide attempt was coded on 56.9% of hospitalizations (most common in major depressive disorder admissions [71.4%, N=36,448 of 51,061]; least common in comorbid eating disorder admissions [11.7%, N=116 of 992]).
TABLE 1. Individual-level characteristics of youths and young adults who used acute mental health services, 2013–2018
 Inpatient hospitalization (N=95,153)Emergency room use (N=108,576)
CharacteristicN%N%
Age in years    
 12–1739,33741.337,39334.4
 18–2755,81658.771,18365.6
Female53,45356.262,85757.9
Health plan type    
 Basic, major medical, comprehensive2,8903.02,7212.5
 Preferred provider organization56,29659.262,13857.2
 High deductible, consumer driven16,22117.120,19318.6
 All other health plansa19,74620.823,52421.7
Pediatric medical complexity    
 Nonchronic58,78861.876,42370.4
 Noncomplex chronic22,23823.420,94719.3
 Complex chronic14,12714.911,20610.3
Left against medical advice1,4471.5
Length of stay in days    
 ≤325,72827.0  
 4–636,87938.8  
 7–1020,74121.8  
 ≥1111,80512.4  
Primary reason for admission    
 Schizophrenia4,5654.81,3921.3
 Bipolar disorder21,22522.37,3226.7
 Major depression51,06153.724,92223.0
 Anxiety disorders, phobias2,1522.347,82644.1
 Posttraumatic stress disorder811.9607.6
 Other psychotic disorders3,3263.52,9642.7
 Disruptive disorders9501.04,0403.7
 Substance use related (comorbid)b8,9469.48,3097.7
 Eating disorders (comorbid)b9921.0153.1
Self-harm or suicide-related eventc54,10556.927,65225.5
Established outpatient health care engagement    
 Primary care and mental health care31,81133.428,03625.8
 Mental health care only27,77529.222,39620.6
 Primary care only13,90614.624,27922.4
 None21,66122.833,86531.2
Mental health care follow-up    
 Within 7 days40,61942.731,03328.6
 Within 30 days64,14867.450,40246.4
a
Including exclusive provider organization, health maintenance organization, and point-of-service plans.
b
Patients were included in this group if the primary diagnosis code for the acute event was for substance use or eating disorders (respectively) and a code for schizophrenia, bipolar disorder, major depression, anxiety disorders or phobias, posttraumatic stress disorder, other psychotic disorders, or disruptive disorders was included in any of the remaining diagnosis codes (see Table S2 in the online supplement).
c
Patients were classified as having a self-harm or suicide-related event if either of these diagnosis codes was documented for the acute event (regardless of the mental health conditions above). Some patients did not have a mental health condition (other than a suicide-related event or self-harm), and for this reason, the values for primary reason for admission do not sum to 100% (see Table S2 in the online supplement).
About one-third had used both primary and mental health care during the 6 months before hospitalization, whereas 22.8% had no established outpatient care (Table 1). Established care was most common among those with comorbid eating disorders and least common among those with psychotic disorders (Tables S6 and S7 in the online supplement). Patients who were younger, female, and had complex chronic conditions had a higher prevalence of established outpatient care.
Mental health follow-up was received by 42.7% of patients within 7 days and by 67.4% within 30 days (Table 1). The strongest predictor of mental health follow-up was established outpatient care during the 6 months prior to the hospitalization, with type of established care affecting likelihood of follow-up (Table 2). Compared with those with no established outpatient care, those with both primary care and mental health care had the highest odds of receiving follow-up (within 7 days, AOR=2.81, 95% CI=2.68–2.94), and those with only mental health care were 2.57 times as likely (95% CI=2.45–2.70) to receive mental health follow-up within 7 days of discharge. Among patients with any kind of established care, those with only primary care were the least likely to receive mental health follow-up (within 7 days, AOR=1.20, 95% CI=1.15–1.26). Similar patterns were observed for 30-day follow-up.
TABLE 2. Factors associated with mental health follow-up among youths and young adults after hospitalization for mental health, 2013–2018
 7-day follow-up30-day follow-up
 N%AOR95% CIN%AOR95% CI
Established outpatient health care engagement        
 None (reference)5,68726.3  10,29047.5  
 Primary care and mental health care16,86853.02.812.68–2.9425,19579.23.763.51–4.03
 Mental health care only13,71749.42.572.45–2.7020,95275.43.253.06–3.46
 Primary care only4,34731.31.201.15–1.267,71155.51.291.22–1.35
Age in years        
 18–27 (reference)21,26038.1  34,36061.6  
 12–1719,35949.21.241.20–1.2929,78875.71.421.34–1.51
Sex        
 Male (reference)16,10738.6  26,20162.8  
 Female24,51245.91.141.11–1.1637,94771.01.161.13–1.20
Plan type        
 All other health plans (reference)a8,22541.7  13,06266.2  
 Basic, major medical, comprehensive1,07037.0.83.65–1.061,70258.9.73.53–1.00
 Preferred provider organization24,23243.01.07.93–1.2338,18067.81.07.91–1.27
 High deductible, consumer driven7,09243.71.08.95–1.2211,20469.11.08.94–1.24
Pediatric medical complexity        
 Nonchronic (reference)24,68042.0  39,38067.0  
 Noncomplex chronic9,76043.91.01.98–1.0515,23568.5.98.94–1.02
 Complex chronic6,17943.71.01.97–1.059,53367.5.94.90–.98
Length of stay in days        
 ≤3 (reference)9,70837.7  15,98562.1  
 4–616,38444.41.211.15–1.2825,75069.81.251.20–1.30
 7–109,59146.21.281.21–1.3514,74271.11.301.22–1.39
 ≥114,93641.81.131.06–1.227,67165.01.111.04–1.19
Left against medical advice        
 No (reference)40,13142.8  63,38767.6  
 Yes48833.7.94.83–1.0676152.6.78.69–.88
Primary reason for admission        
 Major depression (reference)23,73846.5  36,92372.3  
 Schizophrenia1,76038.6.83.75–.922,88063.1.83.75–.91
 Bipolar disorder9,10742.9.85.81–.8814,47568.2.81.78–.85
 Anxiety disorders, phobias98645.8.95.88–1.021,50369.8.85.78–.93
 Posttraumatic stress disorder33941.8.74.68–.8154367.0.67.58–.77
 Other psychotic disorders1,29538.9.93.86–1.012,16064.91.02.94–1.11
 Disruptive disorders32834.5.58.50–.6858161.2.55.47–.64
 Substance use related (comorbid)b2,12423.7.46.41–.513,66841.0.37.34–.39
 Eating disorders (comorbid)b52052.4.99.87–1.1372473.0.76.62–.92
Self-harm or suicide-related eventc        
 No (reference)16,30839.7  25,96263.3  
 Yes24,31144.91.081.04–1.1238,18670.61.111.06–1.16
a
Including exclusive provider organization, health maintenance organization, and point-of-service plans.
b
Patients were included in this group if the primary diagnosis code for the acute event was for either substance use or eating disorders and a code for schizophrenia, bipolar disorder, major depression, anxiety disorders or phobias, posttraumatic stress disorder, other psychotic disorders, or disruptive disorders was included in any of the remaining diagnosis codes (see Table S2 in the online supplement).
c
Patients were classified as having a self-harm or suicide-related event if either of these diagnosis codes was documented for the acute event (regardless of the mental health conditions above) (see Table S2 in the online supplement).
In most age groups, each type of established outpatient care predicted mental health follow-up within 7 days (Table S10 in the online supplement). Established mental health outpatient care (with or without primary care) predicted mental health follow-up regardless of primary diagnosis code (Table S12 in the online supplement).
Older age and leaving against medical advice were associated with decreased likelihood of mental health follow-up (Table 2). Female sex, hospitalizations related to self-harm or suicidality, and longer length of stay were associated with increased likelihood of mental health follow-up. Compared with those hospitalized for major depression, those hospitalized for schizophrenia, bipolar disorder, PTSD, disruptive disorders, or comorbid substance use disorder were less likely to receive mental health follow-up within 7 days or 30 days. The primary reasons for hospitalization among those with mental health follow-up within 7 days differed slightly by age group (Table S10 in the online supplement). Of those hospitalized for co-occurring substance use disorder, 23.7% (N=2,124 of 8,946) received follow-up within 7 days (within 30 days, 41.0%, N=3,668 of 8,946), and 42.3% (N=3,780 of 8,946) had follow-up specifically for substance use within 7 days (within 30 days, 53.4%, N=4,780 of 8,946).

ER Visits

Of those who visited the ER for a mental health reason, the average age was 19.5. A majority were female (57.9%), had a preferred provider organization plan type (57.2%), and had no chronic health conditions other than mental disorder (70.4%) (Table 1). The primary diagnosis codes were anxiety disorders or phobias (44.1%) and major depression (23.0%). One in four visits carried a code for self-harm, suicidal ideation, or suicide attempt (most common in major depressive disorder [34.7%, N=8,645 of 24,922]; least common in anxiety disorders [3.7%, N=1,750 of 47,826]).
Nearly one-third lacked established outpatient care before the ER visit. Mental health follow-up was received by 28.6% of patients within 7 days and by 46.4% within 30 days. Any kind of follow-up increased the percentages to 34.1% within 7 days and 55.5% within 30 days (Table S9 in the online supplement).
The strongest predictor of mental health follow-up was established outpatient care (Table 3). Compared with those with no established outpatient care, those with both primary care and mental health care were the most likely to receive follow-up (within 7 days, AOR=4.06, 95% CI=3.72–4.42), and those with established mental health care were 3.48 times as likely (95% CI=3.17–3.82) to receive follow-up within 7 days, after the analyses were adjusted for all other covariates. Among patients with any kind of established care, those with primary care only had the lowest odds of receiving follow-up (within 7 days, AOR=1.22, 95% CI=1.16–1.28).
TABLE 3. Factors associated with mental health follow-up among youths and young adults after emergency room use for mental health, 2013–2018
 7-day follow-up30-day follow-up
 N%AOR95% CIN%AOR95% CI
Established outpatient health care engagement        
 None (reference)5,02214.8  8,86226.2  
 Primary care and mental health care12,59744.94.063.72–4.4219,38869.25.475.10–5.87
 Mental health care only8,92639.93.483.17–3.8214,29663.84.534.16–4.93
 Primary care only4,48818.51.221.16–1.287,85632.41.261.21–1.31
Age in years        
 18–27 (reference)17,22424.2  29,07540.9  
 12–1713,80936.91.421.34–1.5021,32757.01.431.36–1.51
Sex        
 Male (reference)12,34827.0  20,33944.5  
 Female18,68529.71.00.97–1.0330,06347.81.00.97–1.03
Plan type        
 All other health plans (reference)a6,46827.5  10,66545.3  
 Basic, major medical, comprehensive72526.6.96.81–1.151,18643.6.90.74–1.09
 Preferred provider organization18,02129.01.07.95–1.2129,09346.81.06.93–1.20
 High deductible, consumer driven5,81928.81.05.95–1.159,45846.81.06.95–1.16
Pediatric medical complexity        
 Nonchronic (reference)21,26527.8  34,56145.2  
 Noncomplex chronic6,33230.21.01.98–1.0410,20848.71.02.98–1.05
 Complex chronic3,43630.7.98.94–1.025,63350.31.00.96–1.05
Primary reason for admission        
 Anxiety disorders, phobias (reference)11,55124.2  18,86439.4  
 Schizophrenia36826.4.90.75–1.0865647.11.02.85–1.22
 Bipolar disorder2,41433.01.03.93–1.144,07055.61.221.12–1.34
 Major depression9,42037.81.351.28–1.4214,69659.01.521.46–1.59
 Posttraumatic stress disorder24139.71.421.13–1.7834356.51.301.12–1.51
 Other psychotic disorders67022.6.89.79–1.001,21941.11.05.93–1.17
 Disruptive disorders1,23130.5.83.77–.902,05450.8.91.82–1.01
 Substance use related (comorbid)b1,57418.9.62.59–.662,80433.8.62.59–.66
 Eating disorders (comorbid)b6945.11.371.05–1.7810166.01.38.97–1.95
Self-harm or suicide-related eventc        
 No (reference)21,55126.6  35,30443.6  
 Yes9,48234.31.201.12–1.2715,09854.61.291.23–1.36
a
Including exclusive provider organization, health maintenance organization, and point-of-service plans.
b
Patients were included in this group if the primary diagnosis code for the acute event was for either substance use or eating disorders and a code for schizophrenia, bipolar disorder, major depression, anxiety disorders or phobias, posttraumatic stress disorder, other psychotic disorders, or disruptive disorders was included in any of the remaining diagnosis codes (see Table S2 in the online supplement).
c
Patients were classified as having a self-harm or suicide-related event if either of these diagnosis codes was documented for the acute event (regardless of the mental health conditions above) (see Table S2 in the online supplement).
In most age groups, each type of established outpatient care predicted mental health follow-up within 7 days (Table S11 in the online supplement). Established outpatient mental health care (with or without primary care) predicted mental health follow-up regardless of the primary diagnosis code (Table S13 in the online supplement). Older age was associated with decreased likelihood of receiving mental health follow-up, and self-harm or a suicide-related event was associated with increased likelihood of follow-up (Table 3).
Compared with anxiety disorders or phobias, increased likelihood of receiving follow-up was observed for those with major depression, PTSD, or bipolar disorder (30 days only); those using the ER for disruptive disorders (7 days only) and comorbid substance use were less likely to receive follow-up care. The primary reasons for ER use among those with mental health follow-up within 7 days differed slightly by age group (Table S11 in the online supplement). Of those with ER visits for substance use, 18.9% (N=1,574 of 8,309) received mental health follow-up within 7 days (within 30 days, 33.8%, N=2,804 of 8,309), and 11.5% (N=957 of 8,309) received follow-up specifically for substance use within 7 days (within 30 days, 17.9%, N=1,485 of 8,309).

Discussion

Over 50% of the privately insured youths and young adults in our data set lacked mental health follow-up within 7 days of a hospitalization or ER use for a mental health reason. Established outpatient care was the strongest predictor of follow-up. Those with self-harm or suicide ideation or attempt were more likely to receive follow-up, yet over 50% did not receive follow-up within 7 days of acute service use. Rates of follow-up (mental health and substance use specific) were notably low among those with comorbid substance use disorder.
Our findings were consistent with those of previous research indicating that having established care increases the likelihood of receiving follow-up care after acute service use (12). To our knowledge, this was the first study to show that type of established care affects rates of follow-up. Youths and young adults with both established primary care and mental health care were the most likely to receive mental health follow-up. These results highlight that having both established primary care and mental health care is essential to improving follow-up after acute mental health care use. Given the documented shortage of mental health professionals (20), primary care has become the de facto mental health care system (21). Our study suggested that primary care alone may be less able to connect youths and young adults who have mental health conditions to recommended specialty care in a timely manner. Improving rates of follow-up after acute service use for mental health conditions is one of many reasons to support national efforts to integrate primary and mental health care (2225). In addition, increased access to coordinated specialty care would likely benefit many of these youths, especially those experiencing first-episode psychosis (26). Coordinated specialty care is a team-based, recovery-oriented intervention demonstrated to decrease hospitalization rates and increase education and employment rates (27).
Alarming suicide trends among youths have been documented (28, 29) and exacerbated by the COVID-19 pandemic (30, 31). Suicide risk is significantly increased after ER use or hospitalization (32). In several studies, follow-up care after acute service use for suicide attempt has been associated with lower risk of suicide reattempt and suicide, making this care particularly important for those engaging in self-harm or experiencing suicidal ideation (10, 33). A majority of hospitalizations were related to suicidal ideation or suicide attempt, yet 55.1% of those experiencing suicide-related symptoms did not receive follow-up after discharge. ER use related to suicide attempt or suicidal ideation was relatively low, likely because ER visits resulting in a hospitalization were included in the inpatient sample. This factor may have produced an ER sample that disproportionately included those with anxiety disorders or phobias, which had the lowest prevalence of suicide-related symptoms. Given these considerations, the 65.7% of patients who did not receive follow-up within 7 days of an ER visit related to suicide represent a major gap in care. Efforts such as the Zero Suicide initiative (34) aim to prevent suicide for those under the care of health systems. An effort to improve transitions in care through increased follow-up after acute service use could target suicide prevention among high-risk youths, potentially by requiring those with suicide risk factors to have follow-up appointments at hospital discharge. In addition, the potential iatrogenic effects of inpatient psychiatric care emphasize the need to prevent hospitalization entirely (35), possibly via national efforts such as the 988 hotline to provide specialized care during a mental health crisis (36).
About one-third of those who came to the ER for a mental health condition lacked established outpatient care, and <50% received mental health follow-up within 30 days of discharge. Low rates of outpatient health care utilization have been documented (3739) among the young adult population. Because the patients in our study were privately insured and had a documented psychiatric diagnosis, these low rates are concerning. ER care is typically less comprehensive and shorter than inpatient hospitalization, providing less opportunity to set up follow-up care. This missed opportunity could be improved by increasing utilization of case management (40) and by requiring patients to have a follow-up appointment at discharge. Of all mental health conditions explored, those with comorbid substance use as the primary reason for ER use had the lowest rates of follow-up care (overall and substance use specific). Recent efforts have focused on follow-up care for adults with comorbid substance use disorder, because of the high rates of hospital readmission and postdischarge mortality among this population (41). Considering the rising rates of substance use–related deaths (42) and youth-related concerns (43), these trends require more detailed research.
The study was limited in that mental health condition was identified only through diagnostic codes, because no information regarding functional status was available. However, the validity of administrative claims data and diagnostic codes for identifying psychiatric diagnoses has been documented (16, 44). We also lacked information on race-ethnicity and other social determinants of health. In addition, mental health care may have been received in settings not included in the database, such as schools or out-of-network facilities. Nevertheless, to our knowledge, this study was the first to examine the associations between established outpatient care and mental health follow-up rates after acute mental health care use among privately insured youths.

Conclusions

These findings underscore the importance of increasing rates of established outpatient mental health and primary care to improve mental health follow-up rates after acute service use for mental health reasons among youths and young adults. Integration of primary and mental health care may help achieve optimal follow-up rates. In ER settings, special attention should be given to those with comorbid substance use and those showing signs of self-harm or suicidality.

Acknowledgments

The authors thank the stakeholders involved: representatives from the Young Adult Advisory Board from the Implementation Science and Practice Advances Research Center at the University of Massachusetts Chan Medical School, the National Federation of Families, Got Transition (from the National Alliance to Advance Adolescent Health), Mental Health America, Commonwealth Medicine, and Reliant Medical Group. The opinions expressed here do not necessarily represent the views of these organizations.

Supplementary Material

File (appi.ps.202200047.ds001.pdf)

References

1.
Protecting Youth Mental Health: The US Surgeon General’s Advisory. Washington, DC, Office of the Surgeon General, 2021. https://www.hhs.gov/sites/default/files/surgeon-general-youth-mental-health-advisory.pdf
2.
Adolescent Behaviors and Experiences Survey—United States, January–June 2021. MMWR Suppl 2022; 71:1–34.
3.
Jones SE, Ethier KA, Hertz M, et al: Mental health, suicidality, and connectedness among high school students during the COVID-19 pandemic—adolescent behaviors and experiences survey, United States, January–June 2021. MMWR Suppl 2022; 71:16–21
4.
Torio CM, Encinosa W, Berdahl T, et al: Annual report on health care for children and youth in the United States: national estimates of cost, utilization and expenditures for children with mental health conditions. Acad Pediatr 2015; 15:19–35
5.
Owens PL, McDermott KW, Lipari RN, et al: Emergency Department Visits Related to Suicidal Ideation or Suicide Attempt, 2008–2017. Statistical Brief no 263. Rockville, MD, Agency for Healthcare Research and Quality, 2020. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb263-Suicide-ED-Visits-2008-2017.jsp. Accessed Oct 15, 2021
6.
Heslin KC, Elixhauser A: Mental and Substance Use Disorders Among Hospitalized Teenagers, 2012. Statistical Brief no 202. Rockville, MD, Agency for Healthcare Research and Quality 2016. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb202-Mental-Substance-Use-Teenagers.pdf
7.
Santillanes G, Axeen S, Lam CN, et al: National trends in mental health-related emergency department visits by children and adults, 2009–2015. Am J Emerg Med 2020; 38:2536–2544
8.
Brown J, Scholle SH, Croake S, et al: Development and Testing of Behavioral Health Quality Measures for Health Plans: Final Report. Washington, DC, Office of the Assistant Secretary for Planning and Evaluation, 2015. https://aspe.hhs.gov/sites/default/files/migrated_legacy_files//180236/BHQMfr.pdf
9.
HEDIS Measures and Technical Resources. Washington, DC, National Committee for Quality Assurance, 2021. https://www.ncqa.org/hedis/measures/. Accessed Aug 31, 2021
10.
Fontanella CA, Warner LA, Steelesmith DL, et al: Association of timely outpatient mental health services for youths after psychiatric hospitalization with risk of death by suicide. JAMA Netw Open 2020; 3:e2012887
11.
Beadles CA, Ellis AR, Lichstein JC, et al: First outpatient follow-up after psychiatric hospitalization: does one size fit all? Psychiatr Serv 2015; 66:364–372
12.
Marino L, Wissow LS, Davis M, et al: Predictors of outpatient mental health clinic follow-up after hospitalization among Medicaid-enrolled young adults. Early Interv Psychiatry 2016; 10:468–475
13.
Young Adults With Serious Mental Illness: Some States and Federal Agencies Are Taking Steps to Address Their Transition Challenges. GAO-08-678. Washington, DC, US Government Accountability Office, 2008. https://www.gao.gov/assets/gao-08-678.pdf
14.
Skehan B, Davis M: Aligning mental health treatments with the developmental stage and needs of late adolescents and young adults. Child Adolesc Psychiatr Clin N Am 2017; 26:177–190
15.
Soe K, Babajide A, Gibbs T: APA Official Actions Position Statement on Transitional Aged Youth. Washington, DC, American Psychiatric Association, 2019. www.psychiatry.org/File Library/About-APA/Organization-Documents-Policies/Policies/Position-Transitional-Aged-Youth.pdf
16.
IBM MarketScan Research Databases for Life Sciences Researchers. Somers, NY, IBM Watson Health, 2021. https://www.ibm.com/downloads/cas/OWZWJ0QO. Accessed July 29, 2022
17.
Voss EA, Ma Q, Ryan PB: The impact of standardizing the definition of visits on the consistency of multi-database observational health research. BMC Med Res Methodol 2015; 15:13
18.
Primary Care. Leawood, KS, American Academy of Family Physicians, 2021. https://www.aafp.org/about/policies/all/primary-care.html. Accessed May 6, 2021
19.
Simon TD, Haaland W, Hawley K, et al: Development and validation of the Pediatric Medical Complexity Algorithm (PMCA) version 3.0. Acad Pediatr 2018; 18:577–580
20.
Behavioral Health Workforce Report. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2021. https://annapoliscoalition.org/wp-content/uploads/2021/03/behavioral-health-workforce-report-SAMHSA-2.pdf
21.
Kessler R, Stafford D: Primary care is the de facto mental health system; in Collaborative Medicine Case Studies: Evidence in Practice. Edited by Kessler R, Stafford D. New York, Springer, 2008.
22.
Butler M, Kane RL, McAlpine D, et al: Integration of Mental Health/Substance Abuse and Primary Care. AHRQ pub no 09-E003. Rockville, MD, Agency for Healthcare Research and Quality, 2008. https://www.ahrq.gov/downloads/pub/evidence/pdf/mhsapc/mhsapc.pdf
23.
Wissow LS, van Ginneken N, Chandna J, et al: Integrating children’s mental health into primary care. Pediatr Clin North Am 2016; 63:97–113
24.
Croghan TW, Brown JD: Integrating Mental Health Treatment Into the Patient Centered Medical Home. AHRQ pub no 10-0084-EF. Rockville, MD, Agency for Healthcare Research and Quality, 2010. https://www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/integrating-mental-health-substance-use-treatment.pdf
25.
Hua LL, Alderman EM, Chung RJ, et al: Collaborative care in the identification and management of psychosis in adolescents and young adults. Pediatrics 2021; 147:e2021051486
26.
Heinssen RK, Goldstein AB, Azrin ST: Evidence-Based Treatments for First Episode Psychosis: Components of Coordinated Specialty Care. Bethesda, MD, National Institute of Mental Health, 2014. https://www.nimh.nih.gov/health/topics/schizophrenia/raise/evidence-based-treatments-for-first-episode-psychosis-components-of-coordinated-specialty-care. Accessed Jan 20, 2022
27.
Nossel I, Wall MM, Scodes J, et al: Results of a coordinated specialty care program for early psychosis and predictors of outcomes. Psychiatr Serv 2018; 69:863–870
28.
Curtin SC: State suicide rates among adolescents and young adults aged 10–24: United States, 2000–2018. Natl Vital Stat Rep 2020; 69:1–10
29.
Youth Risk Behavior Survey: Data Summary and Trends Report, 2009–2019. Atlanta, Centers for Disease Control and Prevention, 2020. https://www.cdc.gov/healthyyouth/data/yrbs/pdf/YRBSDataSummaryTrendsReport2019-508.pdf
30.
Racine N, McArthur BA, Cooke JE, et al: Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr 2021; 175:1142–1150
31.
Yard E, Radhakrishnan L, Ballesteros MF, et al: Emergency department visits for suspected suicide attempts among persons aged 12–25 years before and during the COVID-19 pandemic—United States, January 2019–May 2021. MMWR Morb Mortal Wkly Rep 2021; 70:888–894
32.
Ahmedani BK, Westphal J, Autio K, et al: Variation in patterns of health care before suicide: a population case-control study. Prev Med 2019; 127:105796
33.
Ghanbari B, Malakouti SK, Nojomi M, et al: Suicide prevention and follow-up services: a narrative review. Glob J Health Sci 2015; 8:145–153
34.
Stapelberg NJC, Sveticic J, Hughes I, et al: Efficacy of the Zero Suicide framework in reducing recurrent suicide attempts: cross-sectional and time-to-recurrent-event analyses. Br J Psychiatry 2021; 219:427–436
35.
Ward-Ciesielski EF, Rizvi SL: The potential iatrogenic effects of psychiatric hospitalization for suicidal behavior: a critical review and recommendations for research. Clin Psychol Sci Pract 2021; 28:60–71
36.
Krass P, Dalton E, Candon M, et al: Implementing the 988 Hotline: A Critical Window to Decriminalize Mental Health. Washington, DC, Health Affairs Forefront, 2022. https://www.healthaffairs.org/do/10.1377/forefront.20220223.476040. Accessed Mar 31, 2022
37.
Kessler RC, Demler O, Frank RG, et al: Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005; 352:2515–2523
38.
Copeland WE, Shanahan L, Davis M, et al: Increase in untreated cases of psychiatric disorders during the transition to adulthood. Psychiatr Serv 2015; 66:397–403
39.
Lau JS, Adams SH, Irwin CE, et al: Receipt of preventive health services in young adults. J Adolesc Health 2013; 52:42–49
40.
Turner SB, Stanton MP: Psychiatric case management in the emergency department. Prof Case Manag 2015; 20:217–227
41.
Gryczynski J, Nordeck CD, Welsh C, et al: Preventing hospital readmission for patients with comorbid substance use disorder: a randomized trial. Ann Intern Med 2021; 174:899–909
42.
Drug Overdose Deaths in the US Top 100,000 Annually. Hyattsville, MD, National Center for Health Statistics, 2021. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm. Accessed Dec 9, 2021
43.
Levy S: Youth and the opioid epidemic. Pediatrics 2019; 143:e20182752
44.
Nesvåg R, Jönsson EG, Bakken IJ, et al: The quality of severe mental disorder diagnoses in a national health registry as compared to research diagnoses based on structured interview. BMC Psychiatry 2017; 17:93

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services
Psychiatric Services
Pages: 2 - 9
PubMed: 36223162

History

Received: 27 January 2022
Revision received: 5 April 2022
Accepted: 6 May 2022
Published online: 12 October 2022
Published in print: January 01, 2023

Keywords

  1. Adolescents/adolescence
  2. Hospitalization
  3. Primary care
  4. Quality of care
  5. Acute care
  6. Mental health

Authors

Details

Julie Hugunin, B.S. [email protected]
Clinical and Population Health Research doctoral program, Morningside Graduate School of Biomedical Sciences (Hugunin, Davis, Larkin, Baek, Lapane); Department of Psychiatry (Davis, Larkin, Skehan); Department of Emergency Medicine (Larkin); Department of Population and Quantitative Health Sciences (Baek, Lapane); and Department of Pediatrics (Skehan), University of Massachusetts Chan Medical School, Worcester.
Maryann Davis, Ph.D.
Clinical and Population Health Research doctoral program, Morningside Graduate School of Biomedical Sciences (Hugunin, Davis, Larkin, Baek, Lapane); Department of Psychiatry (Davis, Larkin, Skehan); Department of Emergency Medicine (Larkin); Department of Population and Quantitative Health Sciences (Baek, Lapane); and Department of Pediatrics (Skehan), University of Massachusetts Chan Medical School, Worcester.
Celine Larkin, Ph.D.
Clinical and Population Health Research doctoral program, Morningside Graduate School of Biomedical Sciences (Hugunin, Davis, Larkin, Baek, Lapane); Department of Psychiatry (Davis, Larkin, Skehan); Department of Emergency Medicine (Larkin); Department of Population and Quantitative Health Sciences (Baek, Lapane); and Department of Pediatrics (Skehan), University of Massachusetts Chan Medical School, Worcester.
Jonggyu Baek, Ph.D.
Clinical and Population Health Research doctoral program, Morningside Graduate School of Biomedical Sciences (Hugunin, Davis, Larkin, Baek, Lapane); Department of Psychiatry (Davis, Larkin, Skehan); Department of Emergency Medicine (Larkin); Department of Population and Quantitative Health Sciences (Baek, Lapane); and Department of Pediatrics (Skehan), University of Massachusetts Chan Medical School, Worcester.
Brian Skehan, M.D., Ph.D.
Clinical and Population Health Research doctoral program, Morningside Graduate School of Biomedical Sciences (Hugunin, Davis, Larkin, Baek, Lapane); Department of Psychiatry (Davis, Larkin, Skehan); Department of Emergency Medicine (Larkin); Department of Population and Quantitative Health Sciences (Baek, Lapane); and Department of Pediatrics (Skehan), University of Massachusetts Chan Medical School, Worcester.
Kate L. Lapane, Ph.D.
Clinical and Population Health Research doctoral program, Morningside Graduate School of Biomedical Sciences (Hugunin, Davis, Larkin, Baek, Lapane); Department of Psychiatry (Davis, Larkin, Skehan); Department of Emergency Medicine (Larkin); Department of Population and Quantitative Health Sciences (Baek, Lapane); and Department of Pediatrics (Skehan), University of Massachusetts Chan Medical School, Worcester.

Notes

Send correspondence to Ms. Hugunin ([email protected]).
An abstract reporting this work was presented at the annual meeting of the American Psychiatric Association, June 7–10, 2022 (virtual).

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

This research was supported by the National Institute of General Medical Sciences Medical Scientist Training Program (T32-GM-107000) and by a National Center for Advancing Translational Sciences TL1 training grant (TR-001454) from the U.S. National Institutes of Health.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share